Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fosdevirine (GSK2248761) is a selective and potent non-nucleoside reverse transcriptase (NNRTI) inhibitor with anti-HIV activity for the study of neurological related disorders such as late-onset epilepsy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 483.00 | |
10 mg | In stock | $ 692.00 | |
25 mg | In stock | $ 1,080.00 | |
50 mg | In stock | $ 1,490.00 |
Description | Fosdevirine (GSK2248761) is a selective and potent non-nucleoside reverse transcriptase (NNRTI) inhibitor with anti-HIV activity for the study of neurological related disorders such as late-onset epilepsy. |
In vitro | Fosdevirine demonstrates potent in vitro antiviral efficacy against single-point mutations K103N and Y181C, and is similarly effective against the majority of double mutants[1]. |
Synonyms | GSK-2248761A, IDX 899, GSK 2248761A, GSK 2248761, GSK-2248761, IDX-12899, GSK2248761, FDV, GSK2248761A |
Molecular Weight | 413.79 |
Formula | C20H17ClN3O3P |
CAS No. | 1018450-26-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fosdevirine 1018450-26-4 Microbiology/Virology Proteases/Proteasome HIV Protease GSK-2248761A IDX 899 GSK 2248761A GSK 2248761 GSK-2248761 IDX-12899 GSK2248761 FDV GSK2248761A inhibitor inhibit